Published papers
Academic conference presentation
    （Last updated : 2025-11-21 11:34:21）
  NEMOTO Yuuki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Research Associate
■ Published papers
1. Original article　 Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma. 2025/10
2. Original article　 Impact of polypharmacy on perioperative outcomes of robot‐assisted laparoscopic partial nephrectomy for small renal masses. 2025/09
3. Original article　 Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study. 2025/09
4. Original article　 Outcomes of enfortumab vedotin treatment in patients ineligible for the EV‐301 trial. 2025/09
5. Original article　 Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma. 2025/08
Display all(32)
■ Academic conference presentation
1. Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. （ポスター掲示，一般） 2025/09/26
2. Treatment outcomes of enfortumab vedotin in ineligible patients from the EV-301 trial. （ポスター掲示，一般） 2025/04/29
3. Comparison of clinical outcomes between cabozantinib+nivolumab and lenvatinib+pembrolizumab in advanced renal cell carcinoma. （ポスター掲示，一般） 2025/04/28
4. Impact of cytoreductive nephrectomy on immunecheckpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies formetastatic renal cell carcinoma with primary kidneytumors. （ポスター掲示，一般） 2025/04/28
5. Impact of corticosteroid administration on treatment effectiveness in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor-based combination therapy. （ポスター掲示，一般） 2024/05/03
Display all(20)